ライフサイエンスコーパス: Behcet

1 Behcet disease (BD) is a systemic vasculitis with a broa

2 Behcet patients with localized RNFL defects were invited

3 Behcet's disease (BD) is a multi-system inflammatory dis

4 Behcet's disease (BD) is a multisystem disease of unknow

5 Behcet's disease (BD) is a multisystem disorder of unkno

6 Behcet's disease (BD) is a multisystem immune-mediated i

7 Behcet's disease (BD) is a multisystem relapsing inflamm

8 Behcet's disease (BD) is a rare, multisystem inflammator

9 Behcet's disease (BD) is reportedly associated with poly

10 Behcet's disease is a genetically complex disease of unk

11 Behcet's disease is a multisystem inflammatory disorder

12 Behcet's disease is an inflammatory disease characterize

13 Behcet's disease is generally considered to be a multifa

14 Behcet's disease runs a chronic course, with unpredictab

15 Behcet's disease typically arises in young adults, altho

16 Behcet-associated uveitis predominantly affects young me

17 We studied a total of 676 Behcet's disease patients and 1,096 controls.

18 the genetic association between HLA-B*51 and Behcet's disease and exploring additional susceptibility

19 95% confidence interval [CI], 0.19-0.74) and Behcet's disease (aHR, 0.10; 95% CI, 0.01-0.85) were ass

20 between an HLA class I antigen, HLA-B51, and Behcet's disease has long been known.

21 matosus (SLE) in subjects from Colombia; and Behcet's disease (BD) in subjects from Turkey.

22 sic part of familial Mediterranean fever and Behcet's disease management.

23 patients, pars planitis in 16 patients, and Behcet's disease in 13 patients.

24 venile idiopathic arthritis, sarcoidosis and Behcet's disease.

25 enic pathways in the spondyloarthritides and Behcet's disease.

26 angiitis of the central nervous system, and Behcet disease, and the clinical and radiologic features

27 ed the genetic association between UBAC2 and Behcet's disease in 3 independent sets of patients and c

28 aliva from patients with aphthous ulcers and Behcet disease prone to oral ulcers failed to induce NET

29 ly genes with Vogt-Koyanagi-Harada (VKH) and Behcet's disease (BD) in Han Chinese.

30 subset of autoinflammatory diseases, such as Behcet disease, can be caused by rare monogenic variants

31 The genetic association between Behcet's disease and UBAC2 was established, replicated,

32 pothetical patients with uveitic conditions (Behcet disease, birdshot retinochoroiditis, and intermed

33 ssociated with the autoinflammatory disorder Behcet's disease (BD) in epistasis with HLA-B*51, which

34 Most published diagnostic criteria for Behcet's disease include the classic triad of orogenital

35 d the International Study Group criteria for Behcet's disease.

36 ntification of other susceptibility loci for Behcet's disease in multicase families.

37 To discover new susceptibility loci for Behcet's disease, we performed a genome-wide association

38 fied 5 novel genetic susceptibility loci for Behcet's disease.

39 y of alternate, less invasive procedures for Behcet patients.

40 Takayasu arteritis, Wegener granulomatosis, Behcet syndrome, and transplant arteriosclerosis.

41 In Behcet uveitis, localized RNFL defects may be caused by

42 are increasingly used to treat aneurysms in Behcet patients.

43 gest that the robust HLA-B*51 association in Behcet's disease is explained by a variant located betwe

44 Thrombosis is common in Behcet's Syndrome (BS), and there is a need for better b

45 umor necrosis factor, or both, is crucial in Behcet disease-associated relapsing uveitis and that int

46 ate immune response to microbial exposure in Behcet's disease susceptibility.

47 Ocular involvement in Behcet's disease, if untreated, leads to blindness.

48 cause monogenic recessive diseases: MEFV in Behcet's disease and Henoch-Schonlein purpura, and A1AT

49 m and management of large vessel problems in Behcet disease, highlighting contributions over the past

50 anding knowledge on large vessel problems in Behcet's disease, highlighting recent contributions.

51 (GWAS) in vasculitis have been published, in Behcet's disease and Kawasaki disease; none of the genes

52 udy is the first systematic genome screen in Behcet's disease and provides evidence of linkage to sev

53 us to look at the pathologic changes seen in Behcet disease and sarcoidosis in more detail.

54 ave shown an increased rate of thrombosis in Behcet's disease, with a different clinical presentation

55 on in the management of venous thrombosis in Behcet's disease.

56 and mortality of large vessel vasculitis in Behcet disease are beginning to change.

57 and mortality of large vessel vasculitis in Behcet's disease are improving.

58 a number of inflammatory diseases, including Behcet's disease and age-related macular degeneration.

59 analysis of 24,834 variants in 2 independent Behcet's disease cohorts from 2 ancestry groups.

60 r uveitis cases included diagnosis with JIA, Behcet's disease, bilateral uveitis, history of cataract

61 sorders including erythema nodosum leprosum, Behcet's syndrome, discoid lupus erythematosus, and Croh

62 he clinical and radiologic features of neuro-Behcet disease.

63 patients with quiescent, noninfectious, non-Behcet's uveitis (ENDURE study) were enrolled.

64 31 patients with active, noninfectious, non-Behcet's uveitis (INSURE study); and 125 patients with q

65 irst step toward the identification of novel Behcet's disease susceptibility genes.

66 oices of uveitis specialists treating ocular Behcet disease (P = .008).

67 We confirmed the known association of Behcet's disease with HLA-B*51 and identified a second,

68 nd small-vessel vasculitis characteristic of Behcet disease.

69 The neurological complications of Behcet's syndrome have not been characterized with clari

70 An article on the course of Behcet's disease is reviewed as well as another article

71 her characteristic or diagnostic features of Behcet's disease.

72 made in our understanding of the genetics of Behcet disease.

73 Oral ulcers, the hallmark of Behcet's syndrome, can be resistant to conventional trea

74 ers, which are the cardinal manifestation of Behcet's syndrome.

75 ious uveitides (the ocular manifestations of Behcet's disease and sarcoidosis) based on multicolor fl

76 or the treatment of ocular manifestations of Behcet's disease.

77 icacy, the effect on other manifestations of Behcet's syndrome, or the risk of uncommon serious adver

78 ss in patients with a familial occurrence of Behcet's disease.

79 lpha) may play a role in the pathogenesis of Behcet's disease (BD).

80 In the current study of Behcet disease (BD), nonsynonymous variants (NSVs) ident

81 correlated with disease activity in terms of Behcet's Disease Current Activity Form (BDCAF) (p < 0.00

82 as demonstrated efficacy in the treatment of Behcet's disease and other forms of posterior uveitis.

83 The vasculopathy of Behcet's disease is distinctive among the vasculitides i

84 ic syndromes such as rheumatoid arthritis or Behcet's syndrome.

85 as multiple sclerosis, neurosarcoidosis, or Behcet's syndrome.

86 ochromic cyclitis (FHC), and herpes-viral or Behcet's uveitis were analyzed for IL-1beta, -2, -4, -5,

87 nfliximab and interferon alpha, particularly Behcet's disease-associated uveitis.

88 mal set of 5 markers that accurately predict Behcet's disease and sarcoidosis.

89 The disorder resembles Behcet's disease, which is typically considered a polyge

90 nosis of a rheumatologic disorder resembling Behcet disease.

91 genetically well defined, including Still's, Behcet's, and Schnitzler diseases.

92 a patient who had a vasculopathy fitting the Behcet's disease type, but who lacked the other characte

93 lear cells of individuals homozygous for the Behcet's disease-associated "G" allele.

94 litis cases and worse for uveitis related to Behcet disease, Vogt-Koyanagi-Harada disease, or sympath

95 etic effects that increase susceptibility to Behcet's disease in the UBAC2 locus.

96 ve emerged as a successful approach to treat Behcet's disease.

97 We analyzed 1,900 Turkish Behcet's disease cases and 1,779 controls genotyped with

98 Vasculo-Behcet patients are at risk for multiple vessel-related

99 Vasculo-Behcet patients are at risk for multiple vessel-related

100 s (24 eyes) with RNFL defect associated with Behcet uveitis who returned for follow-up, there was a c

101 nous retinal detachment (RD) associated with Behcet's disease (BD).

102 aging features of myelopathy associated with Behcet's disease (BD).

103 teristics of ocular disease in children with Behcet's disease is presented.

104 with 311,459 SNPs in 1,215 individuals with Behcet's disease (cases) and 1,278 healthy controls from

105 genotypes in 1,209 Turkish individuals with Behcet's disease and 1,278 controls.

106 Individuals with Behcet's disease suffer from episodic inflammation often

107 S: This study was including 32 patients with Behcet disease and 32 healthy sex and age-matched contro

108 ulitis occurs in a subgroup of patients with Behcet disease at high risk for disease-related morbidit

109 aware about blood pressure of patients with Behcet disease, especially with long term follow up.

110 color Doppler measurements in patients with Behcet disease.

111 Sixty-two patients with Behcet uveitis (24%) had localized RNFL defect(s) withou

112 ed the clinical photographs of patients with Behcet uveitis (n = 259), ocular toxoplasmosis (n = 120)

113 chemokines and its receptor in patients with Behcet's disease (BD) and their associations with diseas

114 und in the peripheral blood of patients with Behcet's disease during episodes of ocular inflammation.

115 ulitis occurs in a subgroup of patients with Behcet's disease who are at high risk for disease-relate

116 -controlled study in which 111 patients with Behcet's syndrome who had two or more oral ulcers were r

117 A total of 118 patients with Behcet's uveitis (SHIELD study); 31 patients with active

118 A chart review of patients with Behcet-associated uveitis who were evaluated from Januar